Research news
New immunotherapy approach shows promise for treatment-resistant breast cancer
Researchers funded by Breast Cancer Now have developed a new type of antibody that stimulates the immune system to target cancer cells and s...
New research into breast cancer dormancy aims to prevent recurrence
Most breast cancers don’t return after treatment. But in some cases, cancer cells can remain inactive in the body for years before reawakeni...
New discovery reveals more targeted treatment for triple-negative breast cancer
Our researchers reveal that targeting a protein called OTUD6B could be key in preventing aggressive breast cancer cells from continuing to g...
Helping researchers improve radiotherapy resources
Find out how our Breast Cancer Voices have been working to improve radiotherapy resources for those going through breast cancer treatment.
Pathways to the future: A new machine learning predictive tool for lobular breast cancer
Our researchers have developed a new machine learning tool that could help doctors predict long term outcomes and treatment response for peo...
Our top 5 research discoveries in 2024
In 2024, our scientists have made incredible progress. Read about the biggest research breakthroughs of the year.
New ‘triplet therapy’ improves overall survival in advanced breast cancer
A clinical trial, led by one of our scientists, has revealed the benefits of a powerful combination of 3 drugs for aggressive secondary brea...
Celebrating 20 years of our Generations Study
The Breast Cancer Now Generations Study is a landmark project investigating the causes of breast cancer. Read more about what the study's ac...
New research reveals how cancer cells pretend to be ‘super-fit’ to survive and spread
Our researchers uncovered how cancer cells can hijack a natural process called cell competition to help them grow and spread at the expense ...
Researchers identify new target for treating secondary breast cancer in the brain
Our scientists have identified a key factor driving the spread of oestrogen receptor (ER) positive breast cancer to the brain. They hope thi...
New way to kill cancer cells could lead to longer lasting protection for people with breast cancer
Researchers, part-funded by Breast Cancer Now, discovered that killing breast cancer cells in a new way activates the immune system to detec...
Researchers identify what drives PARP inhibitor resistance in secondary breast cancer
Researchers at The Institute of Cancer Research, London, have increased our understanding of how cancer drugs called PARP inhibitors stop wo...
Researchers have furthered our understanding of how the biological clock affects breast cancer
Researchers funded by us have further uncovered how the biological clock affects breast cancer growing and spreading. This new knowledge cou...
Our researchers have discovered a new targeted immunotherapy approach
Funded by us, researchers have discovered a new type of immunotherapy that could stop breast cancer from growing and spreading. They found...
A potential new way to overcome fulvestrant resistance in secondary breast cancer
Scientists have furthered our understanding of how some secondary breast cancers can become resistant to the hormone therapy fulvestrant.
Helping researchers understand people’s experience of bisphosphonates
Our Breast Cancer Voices have helped a team of researchers better understand how people feel about taking bisphosphonates for primary breast...
Measuring the impact of health conditions on partners and family members
Our Breast Cancer Voices helped researchers measure the effect of someone’s health condition on their partners and family members.
Our top 5 research breakthroughs of 2023
Research is the key to stopping breast cancer in its tracks. And our scientists have been working hard throughout the year to better underst...
Scientists find more evidence that exercise lowers your risk of getting breast cancer
Researchers have discovered further evidence that physical activity can reduce people’s chance of developing breast cancer before the menopa...
Potential new drug combination for ER-positive breast cancer
Our scientists have found a potential new way to treat secondary oestrogen receptor (ER) positive breast cancers that have become resistant ...